Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study.
Saved in:
| Title: | Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. |
|---|---|
| Authors: | Cheng, Ching-Yuan1,2,3 (AUTHOR) cycheng012@gmail.com, Chuang, Wen-Chen4,5 (AUTHOR) wenzhen222@gmail.com, Lin, Ching-Pin4,6 (AUTHOR) a0982224141@gmail.com, Li, Che-Hsing7,8 (AUTHOR) Che-Hsing.Li@bcm.edu, Chang, Hui-Yi5 (AUTHOR) mskee53@gmail.com, Wu, Wen-Jun4,5 (AUTHOR) 007wu@csmu.edu.tw, Wu, Ming-Fang5,9,10 (AUTHOR) mfwu0111@gmail.com, Ko, Jiunn-Liang5,9,10 (AUTHOR) jlko@csmu.edu.tw |
| Source: | Cancer Chemotherapy & Pharmacology. 2025, Vol. 95 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03445704 |
|---|---|
| DOI: | 10.1007/s00280-024-04734-9 |
